Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening-Reference-Cited by-同舟云学术

Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening

Published:2020-05-15 Issue:5 Volume:16 Page:765-773
ISSN:1550-9389
Container-title:Journal of Clinical Sleep Medicine
language:en
Short-container-title:Journal of Clinical Sleep Medicine

Author:

Murphy Patricia¹,Kumar Dinesh²,Zammit Gary³,Rosenberg Russell⁴,Moline Margaret²

Affiliation:

1. Formerly of Eisai Inc., Woodcliff Lake, New Jersey

2. Eisai Inc., Woodcliff Lake, New Jersey

3. Clinilabs Drug Development Corporation, New York, New York

4. NeuroTrials Research Inc., Atlanta, Georgia

Publisher

American Academy of Sleep Medicine (AASM)

Subject

Clinical Neurology,Neurology,Pulmonary and Respiratory Medicine

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transitioning insomnia patients from zolpidem to lemborexant: A multicenter, open-label study evaluating a next-dose transition approach to insomnia pharmacotherapy;Sleep Medicine: X;2024-12

2. Current and Emerging Sleep Interventions for Older Adults with or without Mild Cognitive Impairment;Current Treatment Options in Neurology;2024-09-04

3. Evaluation of sunobinop for next-day residual effects in healthy participants;Frontiers in Pharmacology;2024-08-19

4. Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials;Drugs & Aging;2024-08-09

5. The interactive walkway provides fit‐for‐purpose fall‐risk biomarkers in the elderly: Comparison of zolpidem and suvorexant;Clinical and Translational Science;2024-07